XML 33 R20.htm IDEA: XBRL DOCUMENT

Income Taxes	6 Months Ended
Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	13. INCOME TAXES Income tax benefit was $3.6 million and $4.4 million for the three and six months ended June 30, 2021, respectively. The income tax benefit for the three and six months ended June 30, 2021 was primarily attributable to the mix of earnings and increased losses in foreign jurisdictions with differing statutory rates, a tax rate change in a foreign jurisdiction, and non-U.S. tax benefits associated with the Company's non-U.S. operations. Income tax provision was $0.5 million and $0.3 million for the three and six months ended June 30, 2020, respectively. The income tax expense for the three and six months ended June 30, 2020 was primarily attributable to foreign operations. A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized through future operations. As a result of the Company’s analysis of all available objective evidence, both positive and negative, as of June 30, 2021, management believes it is more likely than not that the deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its deferred tax assets with the exception of deferred tax assets related to foreign entities in Brazil, Canada, China, Denmark, India, Netherlands, Taiwan and the United Kingdom. The primary difference between the effective tax rate and the statutory tax rate relates to stock-based compensation excess tax benefits and the valuation allowance on the Company’s U.S. losses.

Income Taxes

6 Months Ended

Jun. 30, 2021

13. INCOME TAXES

Income tax benefit was $3.6 million and $4.4 million for the three and six months ended June 30, 2021, respectively. The income tax benefit for the three and six months ended June 30, 2021 was primarily attributable to the mix of earnings and increased losses in foreign jurisdictions with differing statutory rates, a tax rate change in a foreign jurisdiction, and non-U.S. tax benefits associated with the Company's non-U.S. operations.

Income tax provision was $0.5 million and $0.3 million for the three and six months ended June 30, 2020, respectively. The income tax expense for the three and six months ended June 30, 2020 was primarily attributable to foreign operations.

A valuation allowance is provided when it is more likely than not that some portion of the deferred tax assets will not be realized through future operations. As a result of the Company’s analysis of all available objective evidence, both positive and negative, as of June 30, 2021, management believes it is more likely than not that the deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its deferred tax assets with the exception of deferred tax assets related to foreign entities in Brazil, Canada, China, Denmark, India, Netherlands, Taiwan and the United Kingdom.

The primary difference between the effective tax rate and the statutory tax rate relates to stock-based compensation excess tax benefits and the valuation allowance on the Company’s U.S. losses.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References + Details